PhD in Pharmacogenomics 2014 (University of Tuebingen, Germany)
Masters of Biotechnology 2011 (Warsaw University of Life Sciences, Poland)
Bachelor of Science 2009 (Warsaw University of Life Sciences, Poland)
Dr Joanna Achinger-Kawecka is a Group Leader of the 3D Epigenome in Cancer group at the Garvan Institute of Medical Research and Conjoint Lecturer at St Vincent's Clinical School, UNSW Sydney. Joanna completed her PhD in 2014 at the University of Tuebingen, Germany, investigating microRNA signatures as predictive biomarkers for breast cancer treatment outcome.
Following her PhD, Joanna joined the Epigenetics Research laboratory of Prof Susan Clark at the Garvan Institute, where she established cutting-edge experimental and computational approaches to study the 3D genome organization. She has been awarded competitive research funding from CCNSW, NBCF and UNSW and established her own research group in 2023.
The main goal of the group’s research is to understand the role of 3D genome architecture in cancer, including its cell-to-cell and temporal variability. For that, they combine and integrate cutting-edge genomics technology, single-cell epigenome profiling, genome editing and pre-clinical models to study the interplay of the 3D genome and epigenome in cancer and how these 3D epigenome changes can be targeted with epigenetic therapy. Beyond the fundamental discoveries, their main goal is to uncover new therapeutic targets and biomarkers for the treatment of metastatic disease.
|Title of Project and Chief Investigators||Role in Project||Funding Organisation||Start Date||Duration||Total Grant Amount|
3D EPIGENOME AS A TARGET FOR EPIGENETIC THERAPIES IN ENDOCRINE-RESISTANT BREAST CANCER
|PI||National Breast Cancer Foundation Investigator Grant (IIRS)||2021||3 years||$366,000|
Targeting the Three-Dimensional Epigenome in Endocrine Resistant Breast Cancer
|CIA||Cancer Council NSW Project Grant||2020||3 years||$434,000|
Decoding 3D genome architecture in individual single-cells to establish molecular mechanisms of gene regulation in cancer (Achinger-Kawecka J, Clark S, Schmitt A, Rokny H)
|PI||UNSW Cellular Genomics Futures Institute Seed Grant||2020||1 year||$99,000|
Single-Cell Hi-C: A Novel Tool to Identify Key Epigenetic Drivers of Endocrine Resistant Breast Cancer
|PI||Estee Lauder Companies Breast Cancer Campaign||2019||1 year||
Genetic perturbations to the 3D genome architecture: Implications for endocrine resistance in breast cancer (Clark S, Achinger-Kawecka J)
|Co-I||National Breast Cancer Foundation||2017||1 year||
2019 - Best Selected Speaker Prize, 2019 Post-Doc Symposium, Garvan Institute
2018 - CASS Foundation Travel Grant
2017 - The Ian Potter Foundation Travel Grant
2016 - Best Postdoc Prize, 24th St Vincent’s Campus Research Symposium
2016 - Heliflite Young Explorer Award
2015 - Best Oral Presentation Prize, 23rd St Vincent’s Campus Research Symposium
2011 – EU FP7 Marie Curie Initial Training Network “Fighting Drug Failure” Fellowship